A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

NCT04866108 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
49
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Friendship Hospital